Hepatology
Conference Coverage
Harnessing the HIV care continuum model to improve HCV treatment success
Substance use, trauma histories, and mental health problems can negatively affect HCV care engagement.
Conference Coverage
Liver-related deaths decline after Medicaid expansion under ACA
Investment in Medicaid expansions paid off in fewer liver-related deaths and a decrease in racial/ethnic disparities.
News
Semaglutide shows promise in NASH phase 2 study
The drug “bodes well for further study” in a condition with no FDA approved treatments.
FDA/CDC
CDC: Screen nearly all adults, including pregnant women, for HCV
News
AASLD: Liver transplants should proceed despite COVID-19
Immunosuppression may be protective; the advice comes from a document a recently released from AASLD to help hepatologists and liver transplant...
News
HCV screening risk factors in pregnant women need updating
Large study of pregnant women highlights the potential value of universal screening for hepatitis C virus.
News
Screen all adults for hepatitis C, says USPSTF
The U.S. Preventive Services Task Force now recommends that asymptomatic adults ages 18-79 be screened for hepatitis C virus infection.
Conference Coverage
NASH ‘an epidemic of the 21st century’
LOS ANGELES – Recent guidelines recognize the association between diabetes, NAFLD, and NASH, and call for more vigilance and screening tests.
Conference Coverage
What’s new in hepatitis C: Four themes that dominated at the Liver Meeting
BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy,...
Conference Coverage
Hepatitis B debrief: Key themes that emerged at AASLD
BOSTON – Hot topics included HBV natural history, novel therapies, and prevention.